← back to search

Nghia Nguyen

Vietnam National University Ho Chi Minh City · US
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatitis C virus research, Inflammatory Bowel Disease, Hepatitis B Virus Studies, and Liver Disease Diagnosis and Treatment.
h-index
32
citations
3,013
works
164
NIH funding
primary concept
Medicine
email

Recent publications

AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis
Gastroenterology 2023cited by 137position: middledoi
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease
Gastroenterology 2023cited by 93position: middledoi
Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Gastroenterology 2022cited by 65position: firstdoi
Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016
Inflammatory Bowel Diseases 2021cited by 75position: middledoi
Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996–2016
The American Journal of Gastroenterology 2021cited by 64position: middledoi
Digital Health Technologies for Remote Monitoring and Management of Inflammatory Bowel Disease: A Systematic Review
The American Journal of Gastroenterology 2021cited by 64position: firstdoi
Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn’s Disease in Population-Based Cohort Studies
Digestive Diseases and Sciences 2021cited by 61position: middledoi
Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review
Journal of Crohn s and Colitis 2021cited by 52position: firstdoi
Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases
Clinical Gastroenterology and Hepatology 2020cited by 89position: middledoi
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis
Clinical Gastroenterology and Hepatology 2020cited by 54position: middledoi
Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases
The American Journal of Gastroenterology 2019cited by 78position: middledoi
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis
Cochrane Database of Systematic Reviews 2019cited by 64position: firstdoi
Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study
The Journal of Infectious Diseases 2018cited by 97position: middledoi
High body mass index is associated with increased risk of treatment failure and surgery in biologic‐treated patients with ulcerative colitis
Alimentary Pharmacology & Therapeutics 2018cited by 89position: middledoi
Annual Burden and Costs of Hospitalization for High-Need, High-Cost Patients With Chronic Gastrointestinal and Liver Diseases
Clinical Gastroenterology and Hepatology 2018cited by 70position: firstdoi
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses
˜The œLancet. Gastroenterology & hepatology 2018cited by 67position: firstdoi
Obesity Is Independently Associated With Higher Annual Burden and Costs of Hospitalization in Patients With Inflammatory Bowel Diseases
Clinical Gastroenterology and Hepatology 2018cited by 51position: firstdoi
Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response
Alimentary Pharmacology & Therapeutics 2017cited by 14position: middledoi
Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care
BMJ Open Gastroenterology 2015cited by 18position: middledoi
Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis
BMJ Open Gastroenterology 2015cited by 17position: middledoi
Safety and efficacy of entecavir in adefovir‐experienced patients
Journal of Gastroenterology and Hepatology 2014cited by 7position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Siddharth Singh · Bennett University16 papers (2018–2023)William J. Sandborn · Mirati Therapeutics (United States)11 papers (2018–2021)Mindie H. Nguyen · Stanford University5 papers (2014–2018)Lucila Ohno‐Machado · Yale University5 papers (2018–2021)Parambir S. Dulai · Northwestern University4 papers (2018–2021)Christopher Ma · University College London4 papers (2021–2022)Alexander S. Qian · University of California, San Francisco3 papers (2020–2021)Huy N. Trinh · Hanoi Medical University3 papers (2014–2018)Fernando Velayos · Kaiser Permanente San Francisco Medical Center2 papers (2023–2023)Shahnaz Sultan · University of Minnesota2 papers (2023–2023)Glen Lutchman · Palo Alto University2 papers (2014–2015)J. Proudfoot · Veracyte (United States)2 papers (2018–2019)Niels Vande Casteele · Medical Research Council2 papers (2018–2020)Shazia Mehmood Siddique · Allama Iqbal Medical College2 papers (2023–2023)An K. Le · UNSW Sydney2 papers (2017–2018)Larry J. Prokop · Mayo Clinic2 papers (2018–2021)Ashwin N. Ananthakrishnan · Harvard University2 papers (2023–2023)Bing Zhang · University of Southern California2 papers (2015–2019)Huy Nguyen · The Ohio State University2 papers (2014–2015)Khanh K. Nguyen · University of California, Riverside2 papers (2014–2015)